Clinical Trials Directory

Trials / Completed

CompletedNCT00303979

IMPROVE HF: Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting

Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting

Status
Completed
Phase
Study type
Observational
Enrollment
34,810 (actual)
Sponsor
Medtronic Cardiac Rhythm and Heart Failure · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to characterize current management of patients with either heart failure or prior myocardial infarction and left ventricular dysfunction and to assess the effect of education, specific clinical guidelines, reminder systems, comprehensive disease state management tools, benchmarked quality reports, and academic detailing on the use of evidence-based heart failure therapies in cardiology practices. This study is a quality improvement initiative that is being conducted through review of patient records.

Detailed description

IMPROVE HF, the largest US outpatient HF patient registry, has substantially contributed to our knowledge of how systolic HF and post MI left ventricular systolic dysfunction (LVSD) patients are treated in the outpatient setting. The findings of IMPROVE HF clearly support this guideline and may help to establish a model framework for future performance improvement programs for outpatient cardiology practices.

Conditions

Timeline

Start date
2005-05-01
Primary completion
2009-08-01
Completion
2009-08-01
First posted
2006-03-17
Last updated
2019-01-31
Results posted
2012-12-27

Locations

144 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00303979. Inclusion in this directory is not an endorsement.